C. Bone Marrow, Other Similar questions apply to the study of marrow and other homografts.
II. CHARACTERIZATION OF THE RESPONSE OF THE RECIPIENT TO CMV INFECTION
In this program the contractors concentrated most of their efforts upon problems relevant to the transmission of CMV with blood products. Efforts were devoted to the identification of carriers, elucidation of mechanisms pertaining to transmission and activation, and epidemiologic features of CMV infection. Less attention was devoted in the present program to the identification of specific CMV-associated syndromes. Although the presence of CMV correlates with certain clinical syndromes, the widespread occurrence of this virus in the absence of recognizable disease has made difficult the general identification of the etiologic responsibilities of this virus. At 3. "Natural" infection in the child, adolescent or adult. 4. Transmission by blood and other foreign tissues. While our contract program has concentrated on the hazards of blood and its components and to a lesser extent on the kidney as a vehicle of transmission of CMV, it becomes evident that whenever one implicates one of these factors, one must rule out "usual" or "natural" means of transmission. CMV is assumed to be transmitted in many ways, but the precise mechanism is not known in any particular mode. To understand the natural history of CMV infection and disease, many host susceptibility factors have been suspected, and some data are available on each of the host factors cited. We do not know how such factors would operate in different modes of transmission. For example, while the pregnant woman has been reported to have higher rates of CMV cervical infection, is that limited to certain modes of transmission? Is she also more susceptible in general (e.g., to CMV transmitted blood)?
C. Role ofHumoral and Cell-Mediated Immunity CMV is a herpes virus, and many of our concepts regarding the development and efficacy of acquired humoral and cellular immunity following CMV infection are derived from what we know about other herpes viruses. For example, we assume that acquired humoral immunity exists, but that it is not potent enough to preclude reactivation or superinfection. We don't really know how effective specific antibodies are in the host. In immunosuppressed patients the presence of antibodies may be more an index of potential reactivation than of protection. Cell-mediated immunity has been assumed to be operative and important, but most of the evidence is indirect and circumstantial. We don't know how long immunity lasts. D. Mechanism ofPersistence, Latency, and Reactivation 1. Site of latency (organ, tissue, cell, and subcellular structure).
Mechanisms of reactivation (immunosuppression, allograft reaction, etc.).
It is a truism that CMV produces chronic, persistent, and possibly latent infections which are activated under certain conditions. This important property of the virus should be studied at all levels, particularly in view of the rapid advances in the study of latency of other herpes viruses. The nature and site of infection at the subcellular, cellular, and host level and the mechanisms of reactivation at the cellular and host level should be understood. E. The Immunological Implications of CMVInfection It is clear now that besides stimulating classical humoral and cell-mediated immunity following infection, this virus produces other profound immunological changes in the host, and in turn immunological changes in the host produced by other methods have a profound effect on CMV infection and disease. 
